PHASE Ⅲ TRIAL OF WBRT VERSUS ERLOTINIB CONCURRENT WHOLE-BRAIN RADIATION THERAPY AS FIRST-LINE TREATMENT FOR PATIENTS WITH MULTIPLE BRAIN METASTASES FROM NON-SMALL-CELL LUNG CANCER(ENTER): A MULTICENTRE, OPEN-LABEL, RANDOMISED STUDY: